Increased Plasmacytoid Dendritic Cells in MS Patients During Relapse
Author Information
Author(s): Longhini Ana Leda F, von Glehn Felipe, Brandão Carlos Otávio, de Paula Rosemeire FO, Pradella Fernando, Moraes Adriel S, Farias Alessandro S, Oliveira Elaine C, Quispe-Cabanillas Juan G, Abreu Cassiana Horta, Damasceno Alfredo, Damasceno Benito P, Balashov Konstantin E, Santos Leonilda MB
Primary Institution: University of Campinas - UNICAMP
Hypothesis
Are plasmacytoid dendritic cells (pDCs) levels different in cerebrospinal fluid of MS patients during relapse compared to remission and non-inflammatory diseases?
Conclusion
MS patients in relapse without treatment have significantly higher levels of pDCs in their cerebrospinal fluid compared to those in remission or with other non-inflammatory diseases.
Supporting Evidence
- MS patients in relapse have a higher percentage of pDCs in CSF compared to those in remission.
- No change in pDC levels was observed in peripheral blood.
- The study provides the first observation of increased pDCs in CSF during a specific phase of MS.
Takeaway
When people with multiple sclerosis have a relapse, a type of immune cell called plasmacytoid dendritic cells shows up more in their spinal fluid, which might be linked to how their body is fighting the disease.
Methodology
Flow cytometry was used to measure pDC levels in cerebrospinal fluid and peripheral blood from MS patients in different phases of the disease.
Limitations
The study excluded patients using corticosteroids or other immunosuppressive drugs, which may limit the generalizability of the findings.
Participant Demographics
6 patients in relapse phase, 11 in remission phase, and 8 with other non-inflammatory neurological diseases.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website